Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sanjay Popat

Showing results (81-90 of 272) with videos related to

Pageof 28
Sort By:
JTO Clinical and Research Reports|October 13, 2025
Durable Response to Lenvatinib in Platinum-Refractory Metastatic High-Grade Thymic Mucoepidermoid Carcinoma: A Case ReportNoa Amin, Thanika Ketpueak, Simon Jordan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancerKinga Malottki, Sanjay Popat, Jonathan J Deeks, et al.
Pharmacogenomics|November 7, 2013
EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancerRamon Andrade de Mello, Pedro Madureira, Liliana S Carvalho, et al.
Anticancer Research|March 14, 2007
Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patientsSanjay Popat, Dongbing Zhao, Zhengming Chen, et al.
Journal of Comparative Effectiveness Research|August 21, 2025
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primerAlind Gupta, Stephen Duffield, Cal Shephard, et al.
International Journal of Palliative Nursing|August 24, 2006
Palliative treatments for patients with inoperable gastroesophageal cancersSanjay Popat, Juanita Lopez, Sam Chan, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?Kate Sumpter, Catherine Harper-Wynne, Cheng Yeoh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 11, 2020
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?Sanjay Popat, Christian Grohé, Jesus Corral, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2017
Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center ExperienceNadza Tokaca, Sarah Barth, Mary O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survivalBhawna Sirohi, Sue Ashley, Alison Norton, et al.
Pageof 28

Showing results (81-90 of 272) with videos related to

Sort By:
Pageof 28
JTO Clinical and Research Reports|October 13, 2025
Durable Response to Lenvatinib in Platinum-Refractory Metastatic High-Grade Thymic Mucoepidermoid Carcinoma: A Case ReportNoa Amin, Thanika Ketpueak, Simon Jordan, et al.
Lung Cancer (Amsterdam, Netherlands)|January 19, 2016
Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancerKinga Malottki, Sanjay Popat, Jonathan J Deeks, et al.
Pharmacogenomics|November 7, 2013
EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancerRamon Andrade de Mello, Pedro Madureira, Liliana S Carvalho, et al.
Anticancer Research|March 14, 2007
Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patientsSanjay Popat, Dongbing Zhao, Zhengming Chen, et al.
Journal of Comparative Effectiveness Research|August 21, 2025
Transportability of nonlocal real-world evidence and its relevance to health technology assessment: a primerAlind Gupta, Stephen Duffield, Cal Shephard, et al.
International Journal of Palliative Nursing|August 24, 2006
Palliative treatments for patients with inoperable gastroesophageal cancersSanjay Popat, Juanita Lopez, Sam Chan, et al.
Lung Cancer (Amsterdam, Netherlands)|May 29, 2004
Is the second line data on the use of docetaxel in non-small cell lung cancer reproducible?Kate Sumpter, Catherine Harper-Wynne, Cheng Yeoh, et al.
Lung Cancer (Amsterdam, Netherlands)|May 11, 2020
Anti-angiogenic agents in the age of resistance to immune checkpoint inhibitors: Do they have a role in non-oncogene-addicted non-small cell lung cancer?Sanjay Popat, Christian Grohé, Jesus Corral, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 10, 2017
Molecular Adequacy of Image-Guided Rebiopsies for Molecular Retesting in Advanced Non-Small Cell Lung Cancer: A Single-Center ExperienceNadza Tokaca, Sarah Barth, Mary O'Brien, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 1, 2007
Early response to platinum-based first-line chemotherapy in non-small cell lung cancer may predict survivalBhawna Sirohi, Sue Ashley, Alison Norton, et al.
Pageof 28